Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma

Integrin α5β1 was suggested to be involved in glioblastoma (GBM) aggressiveness and treatment resistance through preclinical studies and genomic analysis in patients. However, further protein expression data are still required to confirm this hypothesis. In the present study, we investigated by immu...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Nelly Etienne-Selloum, Julien Prades, Diana Bello-Roufai, Mathieu Boone, Henri Sevestre, Stéphanie Trudel, Pascal Caillet, Alexandre Coutte, Christine Desenclos, Jean-Marc Constans, Sophie Martin, Laurence Choulier, Bruno Chauffert, Monique Dontenwill
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2021-08-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	biomarker glioblastoma integrin α5 Stupp protocol resistance
Online-Zugang:	https://www.mdpi.com/1424-8247/14/9/882
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!